Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Gain Therapeutics | 2025 | Post-IPO Equity | $7.0M | Bethesda |
| Biosimo | 2025 | Grant | $300K | Zürich |
| Cryowrite | 2025 | Grant | $1.9M | Basel |
| Topadur Pharma | 2024 | Venture - Series Unknown | $3.4M | Schlieren |
| Cellestia | 2023 | Non-equity Assistance | Undisclosed | Basel |
| Zynnon | 2022 | Seed | $836K | Schindellegi |
| Aldena Therapeutics | 2025 | Grant | $656K | Boston |
| Wildbiene + Partner | 2025 | Equity Crowdfunding | $950K | Zürich |
| Hydromea | 2026 | Grant | $1.0M | Renens |
| Perovskia | 2026 | Seed | Undisclosed | Aubonne |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | Gain Therapeutics | Post-IPO Equity | $7.0M | Bethesda, United States |
| 27 | Biosimo | Grant | $300K | Zürich, Switzerland |
| 28 | Cryowrite | Grant | $1.9M | Basel, Switzerland |
| 29 | Topadur Pharma | Venture - Series Unknown | $3.4M | Schlieren, Switzerland |
| 30 | Cellestia | Non-equity Assistance | Undisclosed | Basel, Switzerland |
| 31 | Zynnon | Seed | $836K | Schindellegi, Switzerland |
| 32 | Aldena Therapeutics | Grant | $656K | Boston, United States |
| 33 | Wildbiene + Partner | Equity Crowdfunding | $950K | Zürich, Switzerland |
| 34 | Hydromea | Grant | $1.0M | Renens, Switzerland |
| 35 | Perovskia | Seed | Undisclosed | Aubonne, Switzerland |
Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.
Biosimo Chemicals produces sustainable chemicals
Cryowrite is a sample preparation for cryo-electron microscopy.
Topadur Pharma is a biopharmaceutical company that develops healthcare drugs for the treatment of aging diseases and medical ailments.
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Zynnon develops solutions for risk respiratory infection transmission in hospitals and health facilities.
Aldena Therapeutics is a private biotech startup that invented siRNA-based treatments for dermatological conditions.
Wildbiene + Partner contributes to a balanced ecosystem by providing sustainable pollination and high-quality bee experiences.
Automating submerged asset inspections with a remote underwater drone platform
Perovskia digitally prints custom solar cells based on patent-protected technology.
Nanoflex Robotics develops a telerobotic platform that enables remote treatment of ischemic strokes
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections through an AI-powered technology.
8links offers a multi-layer coating technique for scalable lithium-ion battery manufacture.
Aegis Rider is an augmented reality company that provides spatially anchored information to motorcyclists.
Cytronic AG is the brand for compact and user-friendly linear drives and the market leader with the worldwide unique electric cylinder.
Adoram Therapeutics is a company that uses the benefits of allosteric biochemistry to develop novel therapies.
Noriware is a packaging materials manufacturing company that offers seaweed-based packaging film composed of natural materials.
OncoSwab is creating a point-of-care test to detect lung cancer in high-risk individuals.
Encelta T-cell therapy target and eliminate both blood cancers and solid tumors combined with bispecific antibodies.
KOMP-ACT develops innovative electric motion technology for the industrial automation industry for a carbon-neutral future.
Ammonia for Clean Energy - Driving Clean, Sustainable Off-Grid Power Solution
SEED is a spinoff from the Swiss Federal Institute of Technology.
Komed Health is a healthcare collaboration platform that streamlines clinical workflows.
Signifikant Solutions develops data analysis software solutions that measure and optimize marketing campaigns.
Sustainable green energy solutions for greenhouses and farmers.
Innosuisse has invested in 212 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Innosuisse's top investment sectors include Biotechnology, Health Care, Renewable Energy, Therapeutics, Manufacturing. The firm invests across 50 different industry categories.
Among tracked funding rounds, Gain Therapeutics received $7.0M in a Post-IPO Equity round. Innosuisse's total known invested capital is $569.0M.
Innosuisse's average investment size is $3.2M across its portfolio of 212 companies.
Recent Innosuisse portfolio additions include Gain Therapeutics, Biosimo, Cryowrite, Topadur Pharma, Cellestia. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors